Pulse Biosciences, Inc. (PLSE)
45.18
+0.77
(+1.73%)
USD |
NASDAQ |
Nov 20, 12:23
Pulse Biosciences Cash from Investing (Quarterly) : -152.49M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -152.49M |
| June 30, 2026 | -0.09M |
| March 31, 2026 | -0.033M |
| December 31, 2025 | -0.105M |
| September 30, 2025 | -0.062M |
| June 30, 2025 | -0.123M |
| March 31, 2025 | -0.045M |
| December 31, 2024 | -0.053M |
| September 30, 2024 | -0.038M |
| June 30, 2024 | -0.029M |
| March 31, 2024 | -0.005M |
| December 31, 2023 | -0.043M |
| September 30, 2023 | -0.023M |
| June 30, 2023 | -0.016M |
| March 31, 2023 | -0.039M |
| December 31, 2022 | -0.041M |
| September 30, 2022 | -0.062M |
| June 30, 2022 | -0.019M |
| March 31, 2022 | -0.279M |
| December 31, 2021 | -0.134M |
| September 30, 2021 | -0.157M |
| June 30, 2021 | -0.095M |
| Date | Value |
|---|---|
| March 31, 2021 | 7.949M |
| December 31, 2020 | 14.21M |
| September 30, 2020 | -22.57M |
| June 30, 2020 | 8.081M |
| March 31, 2020 | 10.32M |
| December 31, 2019 | 6.525M |
| September 30, 2019 | 6.554M |
| June 30, 2019 | 12.55M |
| March 31, 2019 | -35.73M |
| December 31, 2018 | 6.219M |
| September 30, 2018 | 5.989M |
| June 30, 2018 | 1.91M |
| March 31, 2018 | 12.00M |
| December 31, 2017 | -25.26M |
| September 30, 2017 | 3.842M |
| June 30, 2017 | 0.232M |
| March 31, 2017 | -1.81M |
| December 31, 2016 | -0.221M |
| September 30, 2016 | -13.60M |
| June 30, 2016 | -0.517M |
| March 31, 2016 | -0.039M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Accuray, Inc. | -5.004M |
| Orthofix Medical, Inc. | -14.24M |
| ResMed, Inc. | 392.06M |
| Rockwell Medical, Inc. | 1.756M |
| Microbot Medical, Inc. | 4.546M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.27M |
| Cash from Financing (Quarterly) | 102.87M |
| Free Cash Flow | -63.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2143 |
| Free Cash Flow to Equity (Quarterly) | -15.01M |
| Free Cash Flow to Firm (Quarterly) | -15.42M |
| Free Cash Flow Yield | -1.92% |